Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies* Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, United Kingdom and United States. * Includes a five-year forecast of the industryHighlightsThe global pharmaceuticals market grew by 3.5% in 2011 to reach a value of $782.1 billion.In 2016, the global pharmaceuticals market is forecast to have a value of $971.1 billion, an increase of 24.2% since 2011.Americas accounts for 42.2% of the global pharmaceuticals market value.Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market's value.Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level researchMarket DefinitionThe pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2011 annual average exchange rates.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Pharmaceuticals: Global Industry Almanac, MarketLine
Published on November 2012
Report Summary
Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals
industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and
profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China,
Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore,
South Africa, South Korea, Spain, Sweden, United Kingdom and United States.
* Includes a five-year forecast of the industry
Highlights
The global pharmaceuticals market grew by 3.5% in 2011 to reach a value of $782.1 billion.
In 2016, the global pharmaceuticals market is forecast to have a value of $971.1 billion, an increase of 24.2% since 2011.
Americas accounts for 42.2% of the global pharmaceuticals market value.
Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market's value.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 1/16

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Market Definition
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market
values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency
conversions used in the production of this report have been calculated at constant 2011 annual average exchange rates.
Table of Content
TABLE OF CONTENTS
EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Introduction 35
What is this report about' 35
Who is the target reader' 35
How to use this report 35
Definitions 35
Global Pharmaceuticals 36
Market Overview 36
Market Data 37
Market Segmentation 38
Market outlook 40
Five forces analysis 41
Pharmaceuticals in Asia-Pacific 49
Market Overview 49
Market Data 50
Market Segmentation 51
Market outlook 53
Five forces analysis 54
Pharmaceuticals in Europe 62
Market Overview 62
Market Data 63
Market Segmentation 64
Market outlook 66
Five forces analysis 67
Pharmaceuticals in France 75
Market Overview 75
Market Data 76
Market Segmentation 77
Market outlook 79
Five forces analysis 80
Macroeconomic indicators 88
Pharmaceuticals in Germany 90
Market Overview 90
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 2/16

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Market Data 91
Market Segmentation 92
Market outlook 94
Five forces analysis 95
Macroeconomic indicators 103
Pharmaceuticals in Australia 105
Market Overview 105
Market Data 106
Market Segmentation 107
Market outlook 109
Five forces analysis 110
Macroeconomic indicators 118
Pharmaceuticals in Belgium 120
Market Overview 120
Market Data 121
Market Segmentation 122
Market outlook 124
Five forces analysis 125
Macroeconomic indicators 133
Pharmaceuticals in Brazil 135
Market Overview 135
Market Data 136
Market Segmentation 137
Market outlook 139
Five forces analysis 140
Macroeconomic indicators 148
Pharmaceuticals in Canada 150
Market Overview 150
Market Data 151
Market Segmentation 152
Market outlook 154
Five forces analysis 155
Macroeconomic indicators 163
Pharmaceuticals in China 165
Market Overview 165
Market Data 166
Market Segmentation 167
Market outlook 169
Five forces analysis 170
Macroeconomic indicators 178
Pharmaceuticals in The Czech Republic 180
Market Overview 180
Market Data 181
Market Segmentation 182
Market outlook 184
Five forces analysis 185
Macroeconomic indicators 193
Pharmaceuticals in Denmark 195
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 3/16

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Market Overview 195
Market Data 196
Market Segmentation 197
Market outlook 199
Five forces analysis 200
Macroeconomic indicators 208
Pharmaceuticals in Hungary 210
Market Overview 210
Market Data 211
Market Segmentation 212
Market outlook 214
Five forces analysis 215
Macroeconomic indicators 223
Pharmaceuticals in India 225
Market Overview 225
Market Data 226
Market Segmentation 227
Market outlook 229
Five forces analysis 230
Macroeconomic indicators 238
Pharmaceuticals in Italy 240
Market Overview 240
Market Data 241
Market Segmentation 242
Market outlook 244
Five forces analysis 245
Macroeconomic indicators 253
Pharmaceuticals in Japan 255
Market Overview 255
Market Data 256
Market Segmentation 257
Market outlook 259
Five forces analysis 260
Macroeconomic indicators 268
Pharmaceuticals in Mexico 270
Market Overview 270
Market Data 271
Market Segmentation 272
Market outlook 274
Five forces analysis 275
Macroeconomic indicators 283
Pharmaceuticals in The Netherlands 285
Market Overview 285
Market Data 286
Market Segmentation 287
Market outlook 289
Five forces analysis 290
Macroeconomic indicators 298
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 4/16

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Pharmaceuticals in Norway 300
Market Overview 300
Market Data 301
Market Segmentation 302
Market outlook 304
Five forces analysis 305
Macroeconomic indicators 313
Pharmaceuticals in Poland 315
Market Overview 315
Market Data 316
Market Segmentation 317
Market outlook 319
Five forces analysis 320
Macroeconomic indicators 328
Pharmaceuticals in Russia 330
Market Overview 330
Market Data 331
Market Segmentation 332
Market outlook 334
Five forces analysis 335
Macroeconomic indicators 343
Pharmaceuticals in Singapore 345
Market Overview 345
Market Data 346
Market Segmentation 347
Market outlook 349
Five forces analysis 350
Macroeconomic indicators 358
Pharmaceuticals in South Africa 360
Market Overview 360
Market Data 361
Market Segmentation 362
Market outlook 364
Five forces analysis 365
Macroeconomic indicators 373
Pharmaceuticals in South Korea 375
Market Overview 375
Market Data 376
Market Segmentation 377
Market outlook 379
Five forces analysis 380
Macroeconomic indicators 388
Pharmaceuticals in Spain 390
Market Overview 390
Market Data 391
Market Segmentation 392
Market outlook 394
Five forces analysis 395
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 5/16

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Macroeconomic indicators 403
Pharmaceuticals in Sweden 405
Market Overview 405
Market Data 406
Market Segmentation 407
Market outlook 409
Five forces analysis 410
Macroeconomic indicators 418
Pharmaceuticals in The United Kingdom 420
Market Overview 420
Market Data 421
Market Segmentation 422
Market outlook 424
Five forces analysis 425
Macroeconomic indicators 433
Pharmaceuticals in The United States 435
Market Overview 435
Market Data 436
Market Segmentation 437
Market outlook 439
Five forces analysis 440
Macroeconomic indicators 448
Company Profiles 450
Leading companies 450
Appendix 538
Methodology 538
LIST OF TABLES
Table 1: Global pharmaceuticals market value: $ billion, 2007'11 37
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2011 38
Table 3: Global pharmaceuticals market share: % share, by value, 2011 39
Table 4: Global pharmaceuticals market value forecast: $ billion, 2011'16 40
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2007'11 50
Table 6: Asia'Pacific pharmaceuticals market geography segmentation: $ billion, 2011 51
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2011 52
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2011'16 53
Table 9: Europe pharmaceuticals market value: $ billion, 2007'11 63
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2011 64
Table 11: Europe pharmaceuticals market share: % share, by value, 2011 65
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2011'16 66
Table 13: France pharmaceuticals market value: $ billion, 2007'11 76
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2011 77
Table 15: France pharmaceuticals market share: % share, by value, 2011 78
Table 16: France pharmaceuticals market value forecast: $ billion, 2011'16 79
Table 17: France size of population (million), 2007'11 88
Table 18: France gdp (constant 2000 prices, $ billion), 2007'11 88
Table 19: France gdp (current prices, $ billion), 2007'11 88
Table 20: France inflation, 2007'11 89
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 6/16

7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 21: France consumer price index (absolute), 2007'11 89
Table 22: France exchange rate, 2007'11 89
Table 23: Germany pharmaceuticals market value: $ billion, 2007'11 91
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2011 92
Table 25: Germany pharmaceuticals market share: % share, by value, 2011 93
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2011'16 94
Table 27: Germany size of population (million), 2007'11 103
Table 28: Germany gdp (constant 2000 prices, $ billion), 2007'11 103
Table 29: Germany gdp (current prices, $ billion), 2007'11 103
Table 30: Germany inflation, 2007'11 104
Table 31: Germany consumer price index (absolute), 2007'11 104
Table 32: Germany exchange rate, 2007'11 104
Table 33: Australia pharmaceuticals market value: $ billion, 2007'11 106
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2011 107
Table 35: Australia pharmaceuticals market share: % share, by value, 2011 108
Table 36: Australia pharmaceuticals market value forecast: $ billion, 2011'16 109
Table 37: Australia size of population (million), 2007'11 118
Table 38: Australia gdp (constant 2000 prices, $ billion), 2007'11 118
Table 39: Australia gdp (current prices, $ billion), 2007'11 118
Table 40: Australia inflation, 2007'11 119
Table 41: Australia consumer price index (absolute), 2007'11 119
Table 42: Australia exchange rate, 2007'11 119
Table 43: Belgium pharmaceuticals market value: $ billion, 2007'11 121
Table 44: Belgium pharmaceuticals market geography segmentation: $ billion, 2011 122
Table 45: Belgium pharmaceuticals market share: % share, by value, 2011 123
Table 46: Belgium pharmaceuticals market value forecast: $ billion, 2011'16 124
Table 47: Belgium size of population (million), 2007'11 133
Table 48: Belgium gdp (constant 2000 prices, $ billion), 2007'11 133
Table 49: Belgium gdp (current prices, $ billion), 2007'11 133
Table 50: Belgium inflation, 2007'11 134
Table 51: Belgium consumer price index (absolute), 2007'11 134
Table 52: Belgium exchange rate, 2007'11 134
Table 53: Brazil pharmaceuticals market value: $ billion, 2007'11 136
Table 54: Brazil pharmaceuticals market geography segmentation: $ billion, 2011 137
Table 55: Brazil pharmaceuticals market share: % share, by value, 2011 138
Table 56: Brazil pharmaceuticals market value forecast: $ billion, 2011'16 139
Table 57: Brazil size of population (million), 2007'11 148
Table 58: Brazil gdp (constant 2000 prices, $ billion), 2007'11 148
Table 59: Brazil gdp (current prices, $ billion), 2007'11 148
Table 60: Brazil inflation, 2007'11 149
Table 61: Brazil consumer price index (absolute), 2007'11 149
Table 62: Brazil exchange rate, 2007'11 149
Table 63: Canada pharmaceuticals market value: $ billion, 2007'11 151
Table 64: Canada pharmaceuticals market geography segmentation: $ billion, 2011 152
Table 65: Canada pharmaceuticals market share: % share, by value, 2011 153
Table 66: Canada pharmaceuticals market value forecast: $ billion, 2011'16 154
Table 67: Canada size of population (million), 2007'11 163
Table 68: Canada gdp (constant 2000 prices, $ billion), 2007'11 163
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 7/16

8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 69: Canada gdp (current prices, $ billion), 2007'11 163
Table 70: Canada inflation, 2007'11 164
Table 71: Canada consumer price index (absolute), 2007'11 164
Table 72: Canada exchange rate, 2007'11 164
Table 73: China pharmaceuticals market value: $ billion, 2007'11 166
Table 74: China pharmaceuticals market geography segmentation: $ billion, 2011 167
Table 75: China pharmaceuticals market share: % share, by value, 2011 168
Table 76: China pharmaceuticals market value forecast: $ billion, 2011'16 169
Table 77: China size of population (million), 2007'11 178
Table 78: China gdp (constant 2000 prices, $ billion), 2007'11 178
Table 79: China gdp (current prices, $ billion), 2007'11 178
Table 80: China inflation, 2007'11 179
Table 81: China consumer price index (absolute), 2007'11 179
Table 82: China exchange rate, 2007'11 179
Table 83: Czech Republic pharmaceuticals market value: $ billion, 2007'11 181
Table 84: Czech Republic pharmaceuticals market geography segmentation: $ billion, 2011 182
Table 85: Czech Republic pharmaceuticals market share: % share, by value, 2011 183
Table 86: Czech Republic pharmaceuticals market value forecast: $ billion, 2011'16 184
Table 87: Czech Republic size of population (million), 2007'11 193
Table 88: Czech Republic gdp (constant 2000 prices, $ billion), 2007'11 193
Table 89: Czech Republic gdp (current prices, $ billion), 2007'11 193
Table 90: Czech Republic inflation, 2007'11 194
Table 91: Czech Republic consumer price index (absolute), 2007'11 194
Table 92: Czech Republic exchange rate, 2007'11 194
Table 93: Denmark pharmaceuticals market value: $ billion, 2007'11 196
Table 94: Denmark pharmaceuticals market geography segmentation: $ billion, 2011 197
Table 95: Denmark pharmaceuticals market share: % share, by value, 2011 198
Table 96: Denmark pharmaceuticals market value forecast: $ billion, 2011'16 199
Table 97: Denmark size of population (million), 2007'11 208
Table 98: Denmark gdp (constant 2000 prices, $ billion), 2007'11 208
Table 99: Denmark gdp (current prices, $ billion), 2007'11 208
Table 100: Denmark inflation, 2007'11 209
Table 101: Denmark consumer price index (absolute), 2007'11 209
Table 102: Denmark exchange rate, 2007'11 209
Table 103: Hungary pharmaceuticals market value: $ billion, 2007'11 211
Table 104: Hungary pharmaceuticals market geography segmentation: $ billion, 2011 212
Table 105: Hungary pharmaceuticals market share: % share, by value, 2011 213
Table 106: Hungary pharmaceuticals market value forecast: $ billion, 2011'16 214
Table 107: Hungary size of population (million), 2007'11 223
Table 108: Hungary gdp (constant 2000 prices, $ billion), 2007'11 223
Table 109: Hungary gdp (current prices, $ billion), 2007'11 223
Table 110: Hungary inflation, 2007'11 224
Table 111: Hungary consumer price index (absolute), 2007'11 224
Table 112: Hungary exchange rate, 2007'11 224
Table 113: India pharmaceuticals market value: $ billion, 2007'11 226
Table 114: India pharmaceuticals market geography segmentation: $ billion, 2011 227
Table 115: India pharmaceuticals market share: % share, by value, 2011 228
Table 116: India pharmaceuticals market value forecast: $ billion, 2011'16 229
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 8/16

9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 117: India size of population (million), 2007'11 238
Table 118: India gdp (constant 2000 prices, $ billion), 2007'11 238
Table 119: India gdp (current prices, $ billion), 2007'11 238
Table 120: India inflation, 2007'11 239
Table 121: India consumer price index (absolute), 2007'11 239
Table 122: India exchange rate, 2007'11 239
Table 123: Italy pharmaceuticals market value: $ billion, 2007'11 241
Table 124: Italy pharmaceuticals market geography segmentation: $ billion, 2011 242
Table 125: Italy pharmaceuticals market share: % share, by value, 2011 243
Table 126: Italy pharmaceuticals market value forecast: $ billion, 2011'16 244
Table 127: Italy size of population (million), 2007'11 253
Table 128: Italy gdp (constant 2000 prices, $ billion), 2007'11 253
Table 129: Italy gdp (current prices, $ billion), 2007'11 253
Table 130: Italy inflation, 2007'11 254
Table 131: Italy consumer price index (absolute), 2007'11 254
Table 132: Italy exchange rate, 2007'11 254
Table 133: Japan pharmaceuticals market value: $ billion, 2007'11 256
Table 134: Japan pharmaceuticals market geography segmentation: $ billion, 2011 257
Table 135: Japan pharmaceuticals market share: % share, by value, 2011 258
Table 136: Japan pharmaceuticals market value forecast: $ billion, 2011'16 259
Table 137: Japan size of population (million), 2007'11 268
Table 138: Japan gdp (constant 2000 prices, $ billion), 2007'11 268
Table 139: Japan gdp (current prices, $ billion), 2007'11 268
Table 140: Japan inflation, 2007'11 269
Table 141: Japan consumer price index (absolute), 2007'11 269
Table 142: Japan exchange rate, 2007'11 269
Table 143: Mexico pharmaceuticals market value: $ billion, 2007'11 271
Table 144: Mexico pharmaceuticals market geography segmentation: $ billion, 2011 272
Table 145: Mexico pharmaceuticals market share: % share, by value, 2011 273
Table 146: Mexico pharmaceuticals market value forecast: $ billion, 2011'16 274
Table 147: Mexico size of population (million), 2007'11 283
Table 148: Mexico gdp (constant 2000 prices, $ billion), 2007'11 283
Table 149: Mexico gdp (current prices, $ billion), 2007'11 283
Table 150: Mexico inflation, 2007'11 284
Table 151: Mexico consumer price index (absolute), 2007'11 284
Table 152: Mexico exchange rate, 2007'11 284
Table 153: Netherlands pharmaceuticals market value: $ million, 2007'11 286
Table 154: Netherlands pharmaceuticals market geography segmentation: $ million, 2011 287
Table 155: Netherlands pharmaceuticals market share: % share, by value, 2011 288
Table 156: Netherlands pharmaceuticals market value forecast: $ million, 2011'16 289
Table 157: Netherlands size of population (million), 2007'11 298
Table 158: Netherlands gdp (constant 2000 prices, $ billion), 2007'11 298
Table 159: Netherlands gdp (current prices, $ billion), 2007'11 298
Table 160: Netherlands inflation, 2007'11 299
Table 161: Netherlands consumer price index (absolute), 2007'11 299
Table 162: Netherlands exchange rate, 2007'11 299
Table 163: Norway pharmaceuticals market value: $ billion, 2007'11 301
Table 164: Norway pharmaceuticals market geography segmentation: $ billion, 2011 302
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 9/16

10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 165: Norway pharmaceuticals market share: % share, by value, 2011 303
Table 166: Norway pharmaceuticals market value forecast: $ billion, 2011'16 304
Table 167: Norway size of population (million), 2007'11 313
Table 168: Norway gdp (constant 2000 prices, $ billion), 2007'11 313
Table 169: Norway gdp (current prices, $ billion), 2007'11 313
Table 170: Norway inflation, 2007'11 314
Table 171: Norway consumer price index (absolute), 2007'11 314
Table 172: Norway exchange rate, 2007'11 314
Table 173: Poland pharmaceuticals market value: $ billion, 2007'11 316
Table 174: Poland pharmaceuticals market geography segmentation: $ billion, 2011 317
Table 175: Poland pharmaceuticals market share: % share, by value, 2011 318
Table 176: Poland pharmaceuticals market value forecast: $ billion, 2011'16 319
Table 177: Poland size of population (million), 2007'11 328
Table 178: Poland gdp (constant 2000 prices, $ billion), 2007'11 328
Table 179: Poland gdp (current prices, $ billion), 2007'11 328
Table 180: Poland inflation, 2007'11 329
Table 181: Poland consumer price index (absolute), 2007'11 329
Table 182: Poland exchange rate, 2007'11 329
Table 183: Russia pharmaceuticals market value: $ billion, 2007'11 331
Table 184: Russia pharmaceuticals market geography segmentation: $ billion, 2011 332
Table 185: Russia pharmaceuticals market share: % share, by value, 2011 333
Table 186: Russia pharmaceuticals market value forecast: $ billion, 2011'16 334
Table 187: Russia size of population (million), 2007'11 343
Table 188: Russia gdp (constant 2000 prices, $ billion), 2007'11 343
Table 189: Russia gdp (current prices, $ billion), 2007'11 343
Table 190: Russia inflation, 2007'11 344
Table 191: Russia consumer price index (absolute), 2007'11 344
Table 192: Russia exchange rate, 2007'11 344
Table 193: Singapore pharmaceuticals market value: $ million, 2007'11 346
Table 194: Singapore pharmaceuticals market geography segmentation: $ million, 2011 347
Table 195: Singapore pharmaceuticals market share: % share, by value, 2011 348
Table 196: Singapore pharmaceuticals market value forecast: $ million, 2011'16 349
Table 197: Singapore size of population (million), 2007'11 358
Table 198: Singapore gdp (constant 2000 prices, $ billion), 2007'11 358
Table 199: Singapore gdp (current prices, $ billion), 2007'11 358
Table 200: Singapore inflation, 2007'11 359
Table 201: Singapore consumer price index (absolute), 2007'11 359
Table 202: Singapore exchange rate, 2007'11 359
Table 203: South Africa pharmaceuticals market value: $ billion, 2007'11 361
Table 204: South Africa pharmaceuticals market geography segmentation: $ million, 2007'2011 362
Table 205: South Africa pharmaceuticals market share: % share, by value, 2011 363
Table 206: South Africa pharmaceuticals market value forecast: $ billion, 2011'16 364
Table 207: South Africa size of population (million), 2007'11 373
Table 208: South Africa gdp (constant 2000 prices, $ billion), 2007'11 373
Table 209: South Africa gdp (current prices, $ billion), 2007'11 373
Table 210: South Africa inflation, 2007'11 374
Table 211: South Africa consumer price index (absolute), 2007'11 374
Table 212: South Africa exchange rate, 2007'11 374
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 10/16

11. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 213: South Korea pharmaceuticals market value: $ billion, 2007'11 376
Table 214: South Korea pharmaceuticals market geography segmentation: $ billion, 2011 377
Table 215: South Korea pharmaceuticals market share: % share, by value, 2011 378
Table 216: South Korea pharmaceuticals market value forecast: $ billion, 2011'16 379
Table 217: South Korea size of population (million), 2007'11 388
Table 218: South Korea gdp (constant 2000 prices, $ billion), 2007'11 388
Table 219: South Korea gdp (current prices, $ billion), 2007'11 388
Table 220: South Korea inflation, 2007'11 389
Table 221: South Korea consumer price index (absolute), 2007'11 389
Table 222: South Korea exchange rate, 2007'11 389
Table 223: Spain pharmaceuticals market value: $ billion, 2007'11 391
Table 224: Spain pharmaceuticals market geography segmentation: $ billion, 2011 392
Table 225: Spain pharmaceuticals market share: % share, by value, 2011 393
Table 226: Spain pharmaceuticals market value forecast: $ billion, 2011'16 394
Table 227: Spain size of population (million), 2007'11 403
Table 228: Spain gdp (constant 2000 prices, $ billion), 2007'11 403
Table 229: Spain gdp (current prices, $ billion), 2007'11 403
Table 230: Spain inflation, 2007'11 404
Table 231: Spain consumer price index (absolute), 2007'11 404
Table 232: Spain exchange rate, 2007'11 404
Table 233: Sweden pharmaceuticals market value: $ billion, 2007'11 406
Table 234: Sweden pharmaceuticals market geography segmentation: $ billion, 2011 407
Table 235: Sweden pharmaceuticals market share: % share, by value, 2011 408
Table 236: Sweden pharmaceuticals market value forecast: $ billion, 2011'16 409
Table 237: Sweden size of population (million), 2007'11 418
Table 238: Sweden gdp (constant 2000 prices, $ billion), 2007'11 418
Table 239: Sweden gdp (current prices, $ billion), 2007'11 418
Table 240: Sweden inflation, 2007'11 419
Table 241: Sweden consumer price index (absolute), 2007'11 419
Table 242: Sweden exchange rate, 2007'11 419
Table 243: United Kingdom pharmaceuticals market value: $ billion, 2007'11 421
Table 244: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2011 422
Table 245: United Kingdom pharmaceuticals market share: % share, by value, 2011 423
Table 246: United Kingdom pharmaceuticals market value forecast: $ billion, 2011'16 424
Table 247: United Kingdom size of population (million), 2007'11 433
Table 248: United Kingdom gdp (constant 2000 prices, $ billion), 2007'11 433
Table 249: United Kingdom gdp (current prices, $ billion), 2007'11 433
Table 250: United Kingdom inflation, 2007'11 434
Table 251: United Kingdom consumer price index (absolute), 2007'11 434
Table 252: United Kingdom exchange rate, 2007'11 434
Table 253: United States pharmaceuticals market value: $ billion, 2007'11 436
Table 254: United States pharmaceuticals market geography segmentation: $ billion, 2011 437
Table 255: United States pharmaceuticals market share: % share, by value, 2011 438
Table 256: United States pharmaceuticals market value forecast: $ billion, 2011'16 439
Table 257: United States size of population (million), 2007'11 448
Table 258: United States gdp (constant 2000 prices, $ billion), 2007'11 448
Table 259: United States gdp (current prices, $ billion), 2007'11 448
Table 260: United States inflation, 2007'11 449
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 11/16

12. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 261: United States consumer price index (absolute), 2007'11 449
Table 262: United States exchange rate, 2007'11 449
Table 263: Pfizer Inc.: key facts 450
Table 264: Pfizer Inc.: key financials ($) 451
Table 265: Pfizer Inc.: key financial ratios 451
Table 266: GlaxoSmithKline Plc: key facts 453
Table 267: GlaxoSmithKline Plc: key financials ($) 454
Table 268: GlaxoSmithKline Plc: key financials (£) 455
Table 269: GlaxoSmithKline Plc: key financial ratios 455
Table 270: AstraZeneca PLC: key facts 457
Table 271: AstraZeneca PLC: key financials ($) 458
Table 272: AstraZeneca PLC: key financial ratios 459
Table 273: Merck & Co., Inc.: key facts 461
Table 274: Merck & Co., Inc.: key financials ($) 462
Table 275: Merck & Co., Inc.: key financial ratios 462
Table 276: Daiichi Sankyo Co., Ltd.: key facts 464
Table 277: Daiichi Sankyo Co., Ltd.: key financials ($) 465
Table 278: Daiichi Sankyo Co., Ltd.: key financials (¥) 465
Table 279: Daiichi Sankyo Co., Ltd.: key financial ratios 465
Table 280: Astellas Pharma Inc.: key facts 467
Table 281: Astellas Pharma Inc.: key financials ($) 468
Table 282: Astellas Pharma Inc.: key financials (¥) 468
Table 283: Astellas Pharma Inc.: key financial ratios 468
Table 284: Novartis AG: key facts 470
Table 285: Novartis AG: key financials ($) 471
Table 286: Novartis AG: key financial ratios 471
Table 287: Aché Laboratórios Farmacêuticos S.A.: key facts 473
Table 288: Medley Indústria Farmacêutica Ltd: key facts 474
Table 289: Sanofi: key facts 475
Table 290: Sanofi: key financials ($) 476
Table 291: Sanofi: key financials (') 476
Table 292: Sanofi: key financial ratios 476
Table 293: EMS Sigma Pharma: key facts 478
Table 294: Johnson & Johnson: key facts 479
Table 295: Johnson & Johnson: key financials ($) 480
Table 296: Johnson & Johnson: key financial ratios 480
Table 297: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 482
Table 298: Orifarm A/S: key facts 483
Table 299: Gedeon Richter Plc: key facts 484
Table 300: Gedeon Richter Plc: key financials ($) 485
Table 301: Gedeon Richter Plc: key financials (HUF) 485
Table 302: Gedeon Richter Plc: key financial ratios 485
Table 303: EGIS Pharmaceuticals Plc: key facts 487
Table 304: EGIS Pharmaceuticals Plc: key financials ($) 488
Table 305: EGIS Pharmaceuticals Plc: key financials (HUF) 488
Table 306: EGIS Pharmaceuticals Plc: key financial ratios 488
Table 307: Dr. Reddy's Laboratories Limited: key facts 490
Table 308: Dr. Reddy's Laboratories Limited: key financials ($) 491
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 12/16

13. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 309: Dr. Reddy's Laboratories Limited: key financials (Rs.) 491
Table 310: Dr. Reddy's Laboratories Limited: key financial ratios 491
Table 311: Cipla Limited: key facts 493
Table 312: Cipla Limited: key financials ($) 494
Table 313: Cipla Limited: key financials (Rs.) 494
Table 314: Cipla Limited: key financial ratios 494
Table 315: Ranbaxy Laboratories Limited: key facts 496
Table 316: Ranbaxy Laboratories Limited: key financials ($) 497
Table 317: Ranbaxy Laboratories Limited: key financials (Rs.) 497
Table 318: Ranbaxy Laboratories Limited: key financial ratios 497
Table 319: Lupin Limited: key facts 499
Table 320: Lupin Limited: key financials ($) 500
Table 321: Lupin Limited: key financials (Rs.) 500
Table 322: Lupin Limited: key financial ratios 501
Table 323: Chiesi Farmaceutici S.P.A.: key facts 503
Table 324: Menarini Group, The: key facts 505
Table 325: Takeda Pharmaceutical Company Limited: key facts 506
Table 326: Takeda Pharmaceutical Company Limited: key financials ($) 507
Table 327: Takeda Pharmaceutical Company Limited: key financials (¥) 507
Table 328: Takeda Pharmaceutical Company Limited: key financial ratios 507
Table 329: Mitsubishi Tanabe Pharma Corporation: key facts 509
Table 330: Mitsubishi Tanabe Pharma Corporation: key financials ($) 510
Table 331: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 510
Table 332: Mitsubishi Tanabe Pharma Corporation: key financial ratios 510
Table 333: Eli Lilly and Company: key facts 512
Table 334: Eli Lilly and Company: key financials ($) 513
Table 335: Eli Lilly and Company: key financial ratios 513
Table 336: Polpharma SA: key facts 515
Table 337: Pharmstandard OJSC: key facts 516
Table 338: Pharmstandard OJSC: key financials ($) 516
Table 339: Pharmstandard OJSC: key financials (RUB) 517
Table 340: Pharmstandard OJSC: key financial ratios 517
Table 341: Bayer AG: key facts 519
Table 342: Bayer AG: key financials ($) 520
Table 343: Bayer AG: key financials (') 520
Table 344: Bayer AG: key financial ratios 521
Table 345: Aspen Pharmacare Holdings Ltd: key facts 523
Table 346: Aspen Pharmacare Holdings Ltd: key financials ($) 524
Table 347: Aspen Pharmacare Holdings Ltd: key financials (ZAR) 524
Table 348: Aspen Pharmacare Holdings Ltd: key financial ratios 524
Table 349: Daewoong Pharmaceutical Co., Ltd.: key facts 526
Table 350: Daewoong Pharmaceutical Co., Ltd.: key financials ($) 527
Table 351: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW) 527
Table 352: Daewoong Pharmaceutical Co., Ltd.: key financial ratios 527
Table 353: Hanmi Holdings Co., Ltd.: key facts 529
Table 354: Hanmi Holdings Co., Ltd.: key financials ($) 530
Table 355: Hanmi Holdings Co., Ltd.: key financials (KRW) 530
Table 356: Hanmi Holdings Co., Ltd.: key financial ratios 530
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 13/16

14. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Table 357: Dong-A Pharmaceutical Co., Ltd.: key facts 532
Table 358: Dong-A Pharmaceutical Co., Ltd.: key financials ($) 532
Table 359: Dong-A Pharmaceutical Co., Ltd.: key financials (KRW) 533
Table 360: Dong-A Pharmaceutical Co., Ltd.: key financial ratios 533
Table 361: Almirall S.A.: key facts 535
Table 362: Almirall S.A.: key financials ($) 535
Table 363: Almirall S.A.: key financials (') 536
Table 364: Almirall S.A.: key financial ratios 536
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 14/16

15. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Pharmaceuticals: Global Industry Almanac, MarketLine
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 995.00 Quantity: _____
Corporate License--USD 7 487.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 15/16

16. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Pharmaceuticals: Global Industry Almanac, MarketLine (From Slideshare) Page 16/16